Overuse of asthma rescue inhalers common, varies among practices

Rates of overprescribing of short-acting beta agonist asthma inhalers remain high and vary significantly among practices, according to new data published in the British Journal of General Practice.
Researchers conducted a cross-sectional study to quantify the prevalence of SABA overprescribing and identify predictors that lead to overprescribing. The researchers evaluated 30,694 primary care medical records in February 2020 for patients with asthma aged 5 to 80 years from 117 practices in east London.
Twenty-six percent of patients with asthma were prescribed six or more SABA inhalers in the

Rates of overprescribing of short-acting beta agonist asthma inhalers remain high and vary significantly among practices, according to new data published in the British Journal of General Practice.
Researchers conducted a cross-sectional study to quantify the prevalence of SABA overprescribing and identify predictors that lead to overprescribing. The researchers evaluated 30,694 primary care medical records in February 2020 for patients with asthma aged 5 to 80 years from 117 practices in east London.
Twenty-six percent of patients with asthma were prescribed six or more SABA inhalers in the